Page 273 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 273

Index   251


               patient factors, 206            S
               patient impact, 206             Safety and performance requirements, 228
               probability of patient benefits, 206  Sealing (closure) and assembly process
               product availability, 206             validation, 107–109
               types of benefits, 206          Shelf life, 94
               uncertainty, 205                Simulation study design, 66
              Risk assessment, HAIs            Single-used devices
               behavior                          industrial, 146
                 isolation precautions, 149–150  preliminary sterilization process,
                 standard precautions, 149–150       210–211
               burden/impact of, 138–139         sterilize SAL 10 , 210–212
                                                            -6
               engineering solutions             terminally sterilized product
                 suite/room design, 152              development, 209
               identification, 138             Spinal fusion system sterilization, 18b
               patient-related factors, 137–138  Stability issues, 93–94
                 antibiotics, 143              Stabilizing and protecting solutions (SPS), 16
                 direct person-to-person spread of   Statistical calculations, risk concepts
                   bacteria, 144                 confidence bounds, 175
                 indirect person to person spread of   confidence interval example, 171–173
                   microbes, 144                 nonparametric analysis, 176–177
                 means of transmission, 142–144  parametric analysis, 177–179
                 source of microorganisms, 141–145  point estimation, 170–171
                 susceptible host, 141–142       types, 176–179
               procedural interventions        Statistical significance and functional
                 antimicrobials, 151–152             equivalence
                 postoperative glucose control,   power and sample size considerations,
                   153–154                           equivalence testing, 124
                 postoperative normothermia, 154  sample size, process capability in process
                 prevention, 151                     validation, 124–128
                 surgical asepsis, 154         Steam sterilization, 212
                 surgical clippers, 152        Steam under pressure
               procedural-related characteristics  protection and barriers, HCF, 157–158
                 device-associated infections, 145–146  Sterility assurance, 239–240
                 non-device-associated infections,   reusable devices, 241
                   145–146                     Sterility assurance level (SAL), 222
                 risks based on procedure, 145–149  definition, 2
               risk factors, 137                 probability of survival, definition, 3
               transmission-based isolation    Sterility assurance professionals, 242–243
                   precautions                 Sterilization cycle time
                 health-care personnel attire, 151  aeration, 160
                 nonsurgical setting attire, 151–152  hydrogen peroxide, 160
                 surgical hand scrub, 150–151    hydrogen peroxide/ozone, 161
                 surgical setting attire, 151    peracetic acid, 161
               WHO “Safe Surgery Saves Lives”    temperature, 160
                   initiative, 148             Sterilization validation methodology, 203
              Risk classification, CE-marking for medical   Surgical asepsis, 154
                   device, 227                 Surgical clippers, 152
              Root cause analysis, 99          Surgical hand scrub, 150–151
   268   269   270   271   272   273   274   275